2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Authors
Keywords
-
Journal
Diabetes & Metabolism Journal
Volume 45, Issue 4, Pages 461-481
Publisher
Korean Diabetes Association
Online
2021-07-30
DOI
10.4093/dmj.2021.0156
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19 vaccine prioritisation for type 1 and type 2 diabetes
- (2021) Alvin C Powers et al. Lancet Diabetes & Endocrinology
- Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status
- (2021) Chan-Hee Jung et al. Diabetes & Metabolism Journal
- 2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea
- (2021) Bo-Yeon Kim et al. Journal of Obesity & Metabolic Syndrome
- Short-Term Effects of the Internet-Based Korea Diabetes Prevention Study: 6-Month Results of a Community-Based Randomized Controlled Trial
- (2021) Jin-Hee Lee et al. Diabetes & Metabolism Journal
- Impaired fasting glucose levels in overweight or obese subjects for screening of type 2 diabetes in Korea
- (2020) Jin-Hee Lee et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association
- (2020) Suzanne V. Arnold et al. CIRCULATION
- Education programmes for persons with type 1 diabetes using an insulin pump: A systematic review
- (2020) Karen Rytter et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
- (2020) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus
- (2020) Soon-Jib Yoo et al. Diabetes & Metabolism Journal
- Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis
- (2019) Karla F. S. Melo et al. Diabetology & Metabolic Syndrome
- Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease
- (2019) Dimitrios A. Koutoukidis et al. JAMA Internal Medicine
- Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial
- (2019) Lawrence Blonde et al. DIABETES CARE
- Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
- (2019) David R Matthews et al. LANCET
- Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
- (2018) Zubin Punthakee et al. Canadian Journal of Diabetes
- Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
- (2018) Michael EJ Lean et al. LANCET
- Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
- (2018) Lutz Heinemann et al. LANCET
- Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials
- (2018) Fernanda O. Laranjeira et al. PLoS One
- Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial
- (2018) Gregory P. Forlenza et al. DIABETES CARE
- Outcomes After Metabolic Surgery in Asians—a Meta-analysis
- (2018) Danson Yeo et al. OBESITY SURGERY
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life
- (2017) Julie M. Waldfogel et al. NEUROLOGY
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity: a Systematic Review and Meta-analysis
- (2017) Ricardo Cohen et al. OBESITY SURGERY
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
- (2017) Vanita R Aroda et al. Lancet Diabetes & Endocrinology
- Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial
- (2016) Julio Rosenstock et al. DIABETES CARE
- Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial
- (2016) Julio Rosenstock et al. DIABETES CARE
- Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial
- (2016) Vanita R. Aroda et al. DIABETES CARE
- Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)
- (2016) V. R. Aroda et al. DIABETES OBESITY & METABOLISM
- Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes
- (2016) Ildiko Lingvay et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine
- (2016) Anil Hingorani et al. JOURNAL OF VASCULAR SURGERY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
- (2016) Sripal Bangalore et al. BMJ-British Medical Journal
- Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
- (2016) Sripal Bangalore et al. BMJ-British Medical Journal
- The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial
- (2016) Sultan Linjawi et al. Diabetes Therapy
- The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial
- (2016) Sultan Linjawi et al. Diabetes Therapy
- Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)
- (2015) Francesco Giorgino et al. DIABETES CARE
- Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority study
- (2015) E. Araki et al. DIABETES OBESITY & METABOLISM
- One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial
- (2015) S. C. L. Gough et al. DIABETES OBESITY & METABOLISM
- Comparative efficacy of anti-diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized and non-randomized studies
- (2015) Wenjuan Tang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality
- (2015) Trevor J. Orchard et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study
- (2015) Pablo Aschner et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study
- (2015) Lawrence Blonde et al. LANCET
- Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
- (2015) Suetonia C Palmer et al. LANCET
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
- (2015) Nanna B Finnerup et al. LANCET NEUROLOGY
- Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Rodney A. Hayward et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contribution of Liraglutide in the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira)
- (2014) John B. Buse et al. DIABETES CARE
- Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes
- (2014) D. D'Alessio et al. DIABETES OBESITY & METABOLISM
- Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial
- (2014) Yves Reznik et al. LANCET
- Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes
- (2014) Stephen C L Gough et al. Lancet Diabetes & Endocrinology
- Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes
- (2013) John B. Buse et al. ANNALS OF INTERNAL MEDICINE
- Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus
- (2013) Hsin-Chieh Yeh et al. ANNALS OF INTERNAL MEDICINE
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial
- (2013) Helena W Rodbard et al. Lancet Diabetes & Endocrinology
- Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis
- (2013) Kirstine J Bell et al. Lancet Diabetes & Endocrinology
- Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets
- (2012) J. H. DeVries et al. DIABETES CARE
- Macronutrients, Food Groups, and Eating Patterns in the Management of Diabetes: A systematic review of the literature, 2010
- (2012) M. L. Wheeler et al. DIABETES CARE
- Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)
- (2012) Y. Seino et al. DIABETES OBESITY & METABOLISM
- Insulin Therapy in Type 2 Diabetes Mellitus
- (2012) Jack L. Leahy ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes
- (2011) R. A. Vigersky et al. DIABETES CARE
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
- (2011) T. Battelino et al. DIABETES CARE
- Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month ‘proof-of-concept' study
- (2011) D. R. Owens et al. DIABETES OBESITY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
- (2011) Kun Ho Yoon et al. Diabetes & Metabolism Journal
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus
- (2009) Rodica Pop-Busui et al. CIRCULATION
- Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
- (2009) M. J. Davies et al. DIABETES OBESITY & METABOLISM
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
- (2009) D. Russell-Jones et al. DIABETOLOGIA
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
- (2009) Michael Mauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive Foot Examination and Risk Assessment: A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists
- (2008) A. J.M. Boulton et al. DIABETES CARE
- Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs
- (2008) M. R. Lankisch et al. DIABETES OBESITY & METABOLISM
- A report on the diagnosis of intermediate hyperglycemia in Korea: A pooled analysis of four community-based cohort studies
- (2008) Jee-Young Oh et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A New Look at Screening and Diagnosing Diabetes Mellitus
- (2008) Christopher D. Saudek et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now